Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Teijin Medical Technology is a specialized medical device company focused on the development and manufacture of orthopedic implants and bone substitute materials. As a wholly-owned subsidiary of Teijin Limited, the company integrates advanced material science with clinical expertise to provide solutions for joint reconstruction and spinal surgery. Their product portfolio includes artificial hip and knee joints, spinal fixation systems, and the Osteotrans line of bioabsorbable osteoconductive materials. The company is a leader in utilizing 3D printing technology to create custom-made implants that match specific patient anatomy, improving surgical outcomes. Headquartered in Okayama, Japan, Teijin Medical Technology plays a critical role in the parent company's healthcare business, focusing on the Bone and Joint therapeutic area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TEIJIN MEDICAL TECHNOLOGY.